Security key
92764N102
Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)
CUSIP: 92764N102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 168,432,200
- Total 13F shares
- 110,838,661
- Share change
- +17,561,996
- Total reported value
- $558,775,027
- Put/Call ratio
- 44%
- Price per share
- $5.04
- Number of holders
- 211
- Value change
- +$84,580,503
- Number of buys
- 105
- Number of sells
- 100
Report period
Q2 2025
Institutions
211
Top holders
10
VIR full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Vir Biotechnology, Inc. SEC filings
Vir Biotechnology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92764N102
Recent filing periods:
Top shareholders of VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
11%
from 13D/G
|
16,541,330
|
$107,187,817 | — | 31 Mar 2025 | |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
9.9%
|
16,684,041
|
$108,112,586 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.6%
|
12,807,508
|
$82,992,651 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
5,727,163
|
$37,112,016 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.6%
|
2,684,415
|
$17,396,913 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
2,295,031
|
$14,875,322 | — | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.3%
|
2,248,249
|
$14,568,654 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
1.3%
|
2,216,434
|
$14,362,490 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.96%
|
1,617,228
|
$10,479,638 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.85%
|
1,424,345
|
$9,229,754 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.82%
|
1,374,874
|
$8,909,184 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.67%
|
1,120,400
|
$7,260,192 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.63%
|
1,068,062
|
$6,921,041 | — | 31 Mar 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
1,060,155
|
$6,869,804 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.55%
|
930,320
|
$6,028,475 | — | 31 Mar 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.5%
|
840,433
|
$5,630,901 | — | 31 Mar 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.47%
|
791,611
|
$5,129,639 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.44%
|
742,674
|
$4,812,527 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.41%
|
693,192
|
$4,491,884 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.4%
|
668,789
|
$4,333,753 | — | 31 Mar 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.36%
|
611,608
|
$3,963,220 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.35%
|
596,519
|
$3,865,442 | — | 31 Mar 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.35%
|
591,420
|
$3,832,402 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.32%
|
542,539
|
$3,515,653 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.3%
|
506,704
|
$3,283,441 | — | 31 Mar 2025 | |
| Alta Partners Management Company, L.P. |
13F
|
Company |
0.3%
|
501,917
|
$3,252,422 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.3%
|
500,000
|
$3,240,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.28%
|
477,396
|
$3,093,525 | — | 31 Mar 2025 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.28%
|
473,607
|
$3,068,973 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.28%
|
470,707
|
$3,050,182 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.28%
|
466,737
|
$3,024,456 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.27%
|
459,337
|
$2,976,504 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.26%
|
439,306
|
$2,846,703 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.26%
|
433,378
|
$2,808,289 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.24%
|
405,580
|
$2,628,158 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.21%
|
358,575
|
$2,323,566 | — | 31 Mar 2025 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.2%
|
331,801
|
$2,150,070 | — | 31 Mar 2025 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.18%
|
308,700
|
$2,000,376 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
306,545
|
$1,986,412 | — | 31 Mar 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.17%
|
292,578
|
$1,895,905 | — | 31 Mar 2025 | |
| TWINBEECH CAPITAL LP |
13F
|
Company |
0.17%
|
291,416
|
$1,888,376 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.17%
|
290,676
|
$1,883,580 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.16%
|
272,535
|
$1,766,027 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.16%
|
268,297
|
$1,738,565 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.16%
|
266,005
|
$1,723,712 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.15%
|
260,518
|
$1,688,157 | — | 31 Mar 2025 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.15%
|
258,376
|
$1,674,277 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.15%
|
257,620
|
$1,669,378 | — | 31 Mar 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.15%
|
250,966
|
$1,626,260 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.15%
|
250,000
|
$1,620,000 | — | 31 Mar 2025 |
Institutional Holders of Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) as of Q2 2025
As of 30 Jun 2025,
Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) was held by
211 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
110,838,661 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, BlackRock, Inc., VANGUARD GROUP INC, ARCH Venture Management, LLC, STATE STREET CORP, FMR LLC, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, ORBIMED ADVISORS LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
211
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
230
Q2 2025 holders
211
Holder diff
-19
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.